Antagonizing T cells
http://www.100md.com
《细胞学杂志》
On page 579, Sumen et al. show that some mutant variants of antigens disable T cells by preventing the clustering of MHC molecules at the interface between T cells and antigen-presenting cells (APCs). The results also suggest that integrins are not the entire answer to getting T cells to stop at their targets.
Certain antigen variants, called antagonists, interfere with a T cell's ability to respond to otherwise stimulatory antigens. Although they are often effective only at high concentrations, antagonists may be used—either by pathogens or as therapies against autoimmune diseases—to thwart strong defense responses. But just how they get in the way is unclear. In the new work, the authors show ways in which antagonists hinder the formation of the immunological synapse—the junction between the T cell and the APC that contains peptide-MHC molecules, T cell receptors (TCRs), and adhesion proteins.
Synapses that formed on membranes containing excess antagonists were sparse in MHC clusters. Fewer MHCs means less T cell proliferation and cytokine production, probably because fewer TCRs are engaged. Even long after antagonist was removed, the T cells still did not respond when exposed to active antigens. In their half-active state, T cells migrated past their antigenic targets rather than making the normal full stop.
This crippling of T cell adhesion appears to result from a failure to focus adhesion rather than a failure in integrin activation itself. The ICAM-1 adhesion molecule, which is a measure of active integrins, was equally dense in synapses with or without antagonists. With antagonists, ICAM-1 accumulated in a crescent shape, not the tight circular pattern characteristic of a strong synapse. ICAM-1 is probably pushed into this odd pattern by the continued cell movement.(ICAM-1 forms a sickle-like shape on T ce)
濞ｅ洠鍓濇导鍛閸涱剛杩旈柛娆忓€介埀顒€鍠涚槐婵囩▔瀹ュ棛鈧垶骞嬮幇顏呭床濞达絾娲戠粻锝咁嚈妤︽鍞撮柕鍡曠劍鐢綊鎳￠幇顓炵仐闁圭ǹ娲ょ槐鈺呭Υ閸屾稒鐎紒鏃傚Х婢ф寮堕崘銊ф剑濞存粌楠哥敮顐︽媼濡炲墽绋婇柡澶婂暕濮瑰鏁嶅畝鍐仧闁诡喓鍔忛缁樼▔閻戞﹩鍔冮柡鍌氭矗缁楀鈧绮忛～锕傚绩鐠鸿櫣绉垮〒姘☉閵囧洨鈧娉涢崢銈囨嫻瑜版帗顫夐悹鍥︾串缁辨繄鎷犻悜钘変粡濞寸姾鍩栭崹銊╂偨娴ｅ啰妯堥梺顐ｆ皑閻擄繝骞嬮幋婊勭拨闁挎稑鏈崹婊勭椤掍焦鏆柛鎺嶅嵆閳ь剚姘ㄩ悡锟犲触鎼搭垳绀夊ù鍏兼皑閻濇盯宕￠崘鑼闁诡喓鍔庡▓鎴炴媴濠婂啯鎯傚ù鐘插濠€鎵磾閹寸姷褰查柛鎺斿█濞呭酣濡撮敓锟�Certain antigen variants, called antagonists, interfere with a T cell's ability to respond to otherwise stimulatory antigens. Although they are often effective only at high concentrations, antagonists may be used—either by pathogens or as therapies against autoimmune diseases—to thwart strong defense responses. But just how they get in the way is unclear. In the new work, the authors show ways in which antagonists hinder the formation of the immunological synapse—the junction between the T cell and the APC that contains peptide-MHC molecules, T cell receptors (TCRs), and adhesion proteins.
Synapses that formed on membranes containing excess antagonists were sparse in MHC clusters. Fewer MHCs means less T cell proliferation and cytokine production, probably because fewer TCRs are engaged. Even long after antagonist was removed, the T cells still did not respond when exposed to active antigens. In their half-active state, T cells migrated past their antigenic targets rather than making the normal full stop.
This crippling of T cell adhesion appears to result from a failure to focus adhesion rather than a failure in integrin activation itself. The ICAM-1 adhesion molecule, which is a measure of active integrins, was equally dense in synapses with or without antagonists. With antagonists, ICAM-1 accumulated in a crescent shape, not the tight circular pattern characteristic of a strong synapse. ICAM-1 is probably pushed into this odd pattern by the continued cell movement.(ICAM-1 forms a sickle-like shape on T ce)
|
鐎甸偊鍠曟穱濠囧棘閸モ晝褰�
闁稿繗娅曢弫鐐烘儌閻愵剙顎�
閻犲洤瀚鎴﹀礄閻樻彃缍�
闁瑰吋绮庨崒銊╁即閺夋埈妯�
闁规亽鍔岄悺銊х磼濞嗘劖绠欓柛娆欐嫹
闁告梻濮撮崣鍡涘绩閹増顥�
|